miGut-Health (101095470)

  https://cordis.europa.eu/project/id/101095470

  Horizon Europe (2021-2027)

  Personalised blueprint intestinal health

  Personalised blueprint of chronic inflammation in health-to-disease transition (HORIZON-HLTH-2022-STAYHLTH-02-01)

  eHealth  ·  inflammatory bowel disease  ·  immunology  ·  nutrition  ·  sensors

  2023-01-01 Start Date (YY-MM-DD)

  2026-12-31 End Date (YY-MM-DD)

  € 7,131,243


  Description

The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease. The overall goal is to deliver interdisciplinary solutions (molecular, nutritional, eHealth and patient engagement/empowerment level) for health promotion and disease prevention that would enable active patient engagement in health and self-care management. Taking on this mission, miGut-Health pursues the following strategic goals: - To integrate state-of-the-art omics (molecular, clinical, nutrition, social and environmental) for identification of actionable biomarkers, risk and health promoting factors linked to health-to-disease transition in the general population, IBD high risk persons, as well as IBD patients. - To perform systems-level analyses of chronic inflammation by applying integrative models from omics and clinical data to predict risk for health-to-disease transition in IBD. - To perform a proof-of-concept controlled clinical trial studying a nutrient elimination diet (here: gluten-free diet) and its impact on intestinal inflammation in IBD patients and high-risk individuals. - To exploit the impact of microbiome-derived diet-associated metabolites on gut inflammation reversion and restoration of barrier integrity and function using an innovative co-culture system of primary human intestinal organoids and sorted immune cell subsets. - To develop and apply novel technologies (sensors, mobile apps) to dynamically monitor individual nutrition as well as physical activity and principal health status. - To implement a patient-centered approach for personalized health and self-care engagement targeted at IBD patients, individuals at risk for IBD and the general population as well as tools for health-care professionals.


  Complicit Organisations

1 Israeli organisation participates in miGut-Health.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Denmark REGION HOVEDSTADEN (999654744) DK30113721 participant PUB € 338,625 € 338,625 € 338,625
Israel WEIZMANN INSTITUTE OF SCIENCE (999979306) IL520016858 participant HES € 700,000 € 700,000 € 700,000
Germany UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (999845349) DE814167313 coordinator HES € 2,643,625 € 2,638,625 € 2,638,625
Germany EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (999778419) DE210372698 participant PRC € 487,874 € 487,874 € 327,874
Netherlands ACADEMISCH ZIEKENHUIS GRONINGEN (999914801) NL800866393B01 participant HES € 659,175 € 659,175 € 659,175
Germany CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (999839529) DE811317279 thirdParty HES € 5,000 € 0 € 0
Switzerland ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (999973971) CHE116075613TVA associatedPartner HES € 0 € 0 € 0
Belgium EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (926739941) BE0459814543 participant OTH € 135,950 € 135,950 € 135,950
Lithuania LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS (972782446) LT100005579315 participant HES € 624,995 € 624,995 € 624,995
Germany UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (999857474) DE218618948 participant HES € 714,200 € 714,200 € 714,200
Croatia RESEARCH AND INNOVATION SERVICES DOO ZA USLUGE (884077013) HR62531146422 thirdParty PRC € 160,000 € 0 € 160,000
Sweden OREBRO UNIVERSITY (999650088) SE202100292401 participant HES € 429,924 € 429,924 € 429,924
Italy UNIVERSITA CATTOLICA DEL SACRO CUORE (999915771) IT02133120150 participant HES € 396,875 € 396,875 € 396,875